|
GGNBP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.015400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.962600E-01 |
| Normal-vs-Stage2 |
4.480200E-01 |
| Normal-vs-Stage3 |
3.925800E-01 |
| Normal-vs-Stage4 |
4.216600E-01 |
| Stage1-vs-Stage2 |
7.596200E-01 |
| Stage1-vs-Stage3 |
7.259800E-01 |
| Stage1-vs-Stage4 |
5.233600E-01 |
| Stage2-vs-Stage3 |
9.998800E-01 |
| Stage2-vs-Stage4 |
6.187000E-01 |
| Stage3-vs-Stage4 |
6.137800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.356220E-01 |
| Normal-vs-AfricanAmerican |
4.188600E-01 |
| Normal-vs-Asian |
3.411400E-01 |
| Caucasian-vs-AfricanAmerican |
7.325400E-01 |
| Caucasian-vs-Asian |
4.151000E-01 |
| AfricanAmerican-vs-Asian |
3.125200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.838000E-01 |
| Normal-vs-Female |
2.603800E-02 |
| Male-vs-Female |
1.332780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.205200E-01 |
| Normal-vs-Extreme_Weight |
7.097200E-01 |
| Normal-vs-Obese |
1.191830E-01 |
| Normal-vs-Extreme_Obese |
9.604400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.112000E-01 |
| Normal_Weight-vs-Obese |
5.835600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.749400E-01 |
| Extreme_Weight-vs-Obese |
2.997800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.395600E-01 |
| Obese-vs-Extreme_Obese |
4.269000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.218000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.404300E-03 |
| Normal-vs-Age(61-80Yrs) |
6.919800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.462600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.674970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.602600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.952400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.055440E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.216000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.548800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.073900E-02 |
| Normal-VS-Type2 PRCC |
9.087400E-01 |
| Normal-VS-KIRP CIMP |
4.676600E-01 |
| Normal-VS-Unclassified PRCC |
4.348800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.735600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.520000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.110600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.242200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.847200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.557600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.445800E-01 |
| Normal-vs-N1 |
4.435600E-02 |
| Normal-vs-N2 |
4.202000E-01 |
| N0-vs-N1 |
2.834000E-02 |
| N0-vs-N2 |
7.592800E-01 |
| N1-vs-N2 |
2.627800E-01 |
|
|
